The catastrophic antiphospholipid syndrome (CAPS) is a life-threating variant of the
antiphospholipid syndrome characterized by the development of multiple thrombosis in a …

The catastrophic antiphospholipid syndrome (APS) is the most severe form of APS with
acute multiple organ involvement and small vessel thrombosis. During the 13th International …

The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis …

Abstract The American Society for Apheresis (ASFA) Apheresis Applications Committee is
charged with a review and categorization of indications for therapeutic apheresis. Beginning …

Prepared from the collective plasma of several thousand people, therapeutic intravenous
immunoglobulin (IVIg) consists mostly of human polyspecific IgG. In addition to its use in …

Introduction: Catastrophic antiphospholipid syndrome (CAPS) is a rare, life-threatening
disease. In 1992, Asherson defined it as a widespread coagulopathy related to the …

OBJECTIVE: To compare the clinical spectrum of patients with primary catastrophic
antiphospholipid syndrome (P-CAPS) to those with systemic lupus erythematosus …

Autoimmune diseases (ADs) are a challenge at the intensive care unit. The management of
patients with these diseases in the critical care setting has improved over time since there …

Although less than 1% of patients with the antiphospholipid syndrome (APS) develop the
catastrophic variant known as catastrophic antiphospholipid syndrome (CAPS), its …

Antiphospholipid syndrome (APS) is a multisystem autoimmune condition characterized by
vascular thromboses and/or pregnancy loss associated with persistently positive …